• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    Rexahn Pharmaceuticals, Inc. (RNN)

    -NYSE MKT
    0.36 Down 0.01(1.87%) Feb 12, 4:00PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development7,016  3,253  3,393  
    Selling General and Administrative6,253  4,726  3,144  
    Non Recurring -   -   -  
    Others -   -  42  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (13,269) (7,979) (6,580)
    Income from Continuing Operations
    Total Other Income/Expenses Net(5,046)(1,316)353  
    Earnings Before Interest And Taxes(18,315)(9,295)(6,227)
    Interest Expense206  204   -  
    Income Before Tax(18,522)(9,499)(6,227)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(18,522)(9,499)(6,227)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (18,522) (9,499) (6,227)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (18,522) (9,499) (6,227)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.